|
nasopharyngeal carcinoma |
23 |
|
promoter hypermethylation |
17 |
|
nasopharyngeal carcinoma (npc) |
16 |
|
whole-exome sequencing |
16 |
|
prognostic marker |
15 |
|
metastasis |
14 |
|
cancer susceptibility genes |
13 |
|
early-age onset |
13 |
|
emt |
13 |
|
mst1r |
13 |
|
nasopharyngeal neoplasms - genetics - metabolism - pathology |
13 |
|
apobec-mediated signature |
12 |
|
escc |
12 |
|
microcell-mediated chromosome transfer |
12 |
|
nf-κb signaling |
12 |
|
somatic mutation landscape |
12 |
|
tumor suppressor gene |
12 |
|
dna methylation |
11 |
|
esophageal squamous cell carcinoma |
11 |
|
esophageal squamous cell carcinoma (escc) |
11 |
|
liquid biopsy |
11 |
|
nidogen-2 (nid2) |
11 |
|
signal transduction |
11 |
|
tumor suppression |
11 |
|
tumor suppressor proteins - genetics - metabolism |
11 |
|
antiangiogenesis |
10 |
|
carcinoma, squamous cell - genetics - metabolism - pathology |
10 |
|
cell cycle |
10 |
|
esophageal neoplasms - genetics - metabolism - pathology |
10 |
|
extracellular matrix protein |
10 |
|
tissue microarray |
10 |
|
tumor suppressor |
10 |
|
adam proteins - biosynthesis - genetics - metabolism |
9 |
|
cell cycle arrest |
9 |
|
chromosome 6p |
9 |
|
chromosomes, human, pair 14 - genetics |
9 |
|
dual specificity phosphatase 6 - genetics - metabolism |
9 |
|
dual-specificity phosphatase 6 (dusp6) |
9 |
|
ebv |
9 |
|
endothelial cells - cytology |
9 |
|
enzyme activation |
9 |
|
epithelial-mesenchymal transition |
9 |
|
esophageal neoplasms - blood supply - enzymology - genetics |
9 |
|
genes, tumor suppressor |
9 |
|
genetic predisposition to disease |
9 |
|
genetic susceptibility |
9 |
|
illumina humanmethylation450 |
9 |
|
leucocyte telomere length |
9 |
|
methylome |
9 |
|
mipol1 |
9 |
|
nasopharyngeal neoplasms - blood supply - enzymology - genetics |
9 |
|
npc risk |
9 |
|
survival |
9 |
|
telomere biology |
9 |
|
xenograft |
9 |
|
adaptor proteins, signal transducing - physiology |
8 |
|
apoptosis |
8 |
|
cell line, transformed |
8 |
|
cell transformation, neoplastic - genetics |
8 |
|
chromosome mapping |
8 |
|
circulating neoplastic cell |
8 |
|
circulating tumor cells |
8 |
|
circulating tumor dna |
8 |
|
cytokines - genetics - physiology |
8 |
|
humans |
8 |
|
in situ hybridization, fluorescence |
8 |
|
longitudinal real-time monitoring |
8 |
|
medical sciences |
8 |
|
microsatellite repeats - genetics |
8 |
|
neovascularization, pathologic - genetics |
8 |
|
nf-kappa b - metabolism |
8 |
|
non-invasive biomarker |
8 |
|
oncology |
8 |
|
promoter regions, genetic - genetics |
8 |
|
reverse transcriptase polymerase chain reaction |
8 |
|
transcription regulator |
8 |
|
tumor stem cell assay |
8 |
|
advanced escc |
7 |
|
angiogenesis |
7 |
|
azygos vein blood |
7 |
|
blm |
7 |
|
ccdc170 |
7 |
|
cell line, tumor |
7 |
|
cell-free dna |
7 |
|
chinese |
7 |
|
circulating tumor cells (ctc) |
7 |
|
ctc clusters |
7 |
|
ctc enumeration |
7 |
|
dna dsb repair |
7 |
|
early prediction |
7 |
|
esophageal neoplasms - genetics |
7 |
|
familial npc |
7 |
|
mmp19 |
7 |
|
nhej |
7 |
|
npc |
7 |
|
nucleosome organization |
7 |
|
oesophageal squamous cell carcinoma |
7 |
|
pathway associations |
7 |
|
prognosis |
7 |
|
tert |
7 |
|
whole‐exome sequencing |
7 |
|
znf750 mutation |
7 |
|
adaptor proteins, signal transducing - genetics - metabolism |
6 |
|
alleles |
6 |
|
animals |
6 |
|
anti-angiogenesis |
6 |
|
apoptosis - genetics |
6 |
|
carcinoma, squamous cell - genetics |
6 |
|
carcinoma, squamous cell - metabolism - mortality |
6 |
|
cell signaling |
6 |
|
chromosome deletion |
6 |
|
chromosome segregation |
6 |
|
chromosomes, human, pair 13 - genetics |
6 |
|
crip2 |
6 |
|
ctc |
6 |
|
deoxycytidine - pharmacology |
6 |
|
dna damage repair pathway |
6 |
|
dna methylation - drug effects |
6 |
|
enzyme-linked immunosorbent assay |
6 |
|
epithelial cells - drug effects - pathology |
6 |
|
epstein-barr virus |
6 |
|
epstein−barr virus |
6 |
|
esophageal neoplasms - metabolism - mortality |
6 |
|
gene expression |
6 |
|
gene expression profiling |
6 |
|
gene expression regulation, neoplastic - drug effects |
6 |
|
genome, human - genetics |
6 |
|
histone bivalent switch |
6 |
|
human leukocyte antigen |
6 |
|
hydroxamic acids - pharmacology |
6 |
|
hypermethylation |
6 |
|
inflammation |
6 |
|
invasion |
6 |
|
latent tgf-beta binding proteins - genetics - metabolism |
6 |
|
latent transforming growth factor β binding protein 2 (ltbp-2) |
6 |
|
lim domain proteins - genetics - metabolism |
6 |
|
loh |
6 |
|
ltbp-2 |
6 |
|
metastatic growth |
6 |
|
mice |
6 |
|
microarray analysis |
6 |
|
migration |
6 |
|
mlh1 |
6 |
|
neoplasm transplantation |
6 |
|
nidogen-2 |
6 |
|
npc genetics |
6 |
|
serum biomarker |
6 |
|
thrombospondins - genetics - metabolism |
6 |
|
transfection |
6 |
|
tumor cell dormancy |
6 |
|
tumor cells, cultured |
6 |
|
twist1 |
6 |
|
adam proteins - genetics |
5 |
|
adamts9 |
5 |
|
antioncogenes. |
5 |
|
base sequence |
5 |
|
brca2 |
5 |
|
chromosome 3 |
5 |
|
chromosomes, human, pair 3 |
5 |
|
dna |
5 |
|
esophageal cancer |
5 |
|
esophageal cancer susceptibility gene |
5 |
|
esophageal carcinoma |
5 |
|
gene expression regulation, neoplastic |
5 |
|
la-tam |
5 |
|
loss of heterozygosity |
5 |
|
loss‐of‐function mutations |
5 |
|
lymph node metastasis |
5 |
|
lymphomas-- genetic aspects. |
5 |
|
microcell hybrid |
5 |
|
molecular sequence data |
5 |
|
multi-omics study |
5 |
|
protein translation |
5 |
|
retrotransposon insertion |
5 |
|
spatial analysis |
5 |
|
synthetic lethality |
5 |
|
tumor segregant |
5 |
|
cancer stem cell markers |
4 |
|
carcinogenicity tests |
4 |
|
carcinoma - genetics - pathology |
4 |
|
cell adhesion molecules |
4 |
|
cell line |
4 |
|
chemicals and cas registry numbers |
4 |
|
chromosome 3 transfer |
4 |
|
chromosome 9 |
4 |
|
chromosomes, human, pair 11 - genetics |
4 |
|
chromosomes, human, pair 14 |
4 |
|
chromosomes, human, pair 18 - genetics |
4 |
|
chromosomes, human, pair 9 - genetics |
4 |
|
ct dna |
4 |
|
deleted in esophageal cancer 1 |
4 |
|
diagnosis |
4 |
|
differentially expressed in squamous cell carcinoma 1 |
4 |
|
dna primers |
4 |
|
dna, complementary - genetics |
4 |
|
ebv bart mirnas |
4 |
|
ebv serology |
4 |
|
female |
4 |
|
gene dosage |
4 |
|
gene transfer techniques |
4 |
|
genetic markers |
4 |
|
genomic instability |
4 |
|
hybrid cells |
4 |
|
ibd |
4 |
|
immunoglobulins - genetics |
4 |
|
inherited escc |
4 |
|
innate immune response |
4 |
|
membrane proteins - genetics |
4 |
|
methylation |
4 |
|
mice, nude |
4 |
|
nasopharyngeal neoplasms - genetics - pathology |
4 |
|
ngs analysis |
4 |
|
nucleic acid hybridization |
4 |
|
physiological wnt/β-catenin signaling |
4 |
|
plasma ebv dna |
4 |
|
polq |
4 |
|
polymorphism, single nucleotide |
4 |
|
references (54) view in table layout |
4 |
|
self-renewal network |
4 |
|
snp array |
4 |
|
stemness transition |
4 |
|
telomere length |
4 |
|
transmembrane serine protease |
4 |
|
transplantation, heterologous |
4 |
|
tumor suppressor genes |
4 |
|
tumor suppressor proteins |
4 |
|
bioluminescence imaging |
3 |
|
biomarkers |
3 |
|
cancer prognosis |
3 |
|
cancer progression |
3 |
|
cell signaling pathways |
3 |
|
deleted in oesophageal cancer 1 (dec1) |
3 |
|
dna repair gene |
3 |
|
family health |
3 |
|
fancd2 |
3 |
|
genetic predisposition |
3 |
|
germline polymorphisms |
3 |
|
gwas |
3 |
|
hla |
3 |
|
keratinocyte differentiation |
3 |
|
live animal imaging |
3 |
|
lymphatic metastasis |
3 |
|
oesophageal cancer family history |
3 |
|
orthotopic model |
3 |
|
rpa1 |
3 |
|
squamous cell carcinoma |
3 |
|
subcellular localisation |
3 |
|
telomere |
3 |
|
tumor suppressor proteins - metabolism |
3 |
|
ubiquitination |
3 |
|
zinc finger protein 750 |
3 |
|
adenocarcinoma - drug therapy - genetics - mortality - pathology - surgery |
2 |
|
adult |
2 |
|
aged |
2 |
|
aged, 80 and over |
2 |
|
asian continental ancestry group |
2 |
|
asian continental ancestry group - genetics |
2 |
|
chemotherapy, adjuvant |
2 |
|
china |
2 |
|
china - ethnology |
2 |
|
chromosomes |
2 |
|
codon - genetics |
2 |
|
colonic neoplasms - genetics - mortality - pathology |
2 |
|
colorectal cancer |
2 |
|
colorectal neoplasms - drug therapy - genetics - mortality - pathology - surgery |
2 |
|
colorectal neoplasms - genetics - mortality - pathology |
2 |
|
colorectal neoplasms - genetics - pathology |
2 |
|
disease-free survival |
2 |
|
dna repair |
2 |
|
dna replication |
2 |
|
dna, neoplasm - genetics |
2 |
|
ethnic groups - genetics |
2 |
|
european continental ancestry group - genetics |
2 |
|
expression quantitative trait loci (eqtl) |
2 |
|
familial escc |
2 |
|
familial escc risk |
2 |
|
genes, apc |
2 |
|
genes, dcc |
2 |
|
genes, mcc |
2 |
|
genes, myc |
2 |
|
genes, p53 - genetics |
2 |
|
genes, ras |
2 |
|
genes, ras - genetics |
2 |
|
genome-wide association study (gwas) |
2 |
|
genotype |
2 |
|
hong kong |
2 |
|
japan - ethnology |
2 |
|
ki-ras |
2 |
|
loss of function mutation |
2 |
|
male |
2 |
|
middle aged |
2 |
|
mutation |
2 |
|
neoplasm staging |
2 |
|
ngs |
2 |
|
pathogenic variants |
2 |
|
point mutation |
2 |
|
polymerase chain reaction |
2 |
|
polymerase chain reaction - methods |
2 |
|
polymorphism, restriction fragment length |
2 |
|
proto-oncogene proteins c-myc - genetics |
2 |
|
rad50 |
2 |
|
rectal neoplasms - genetics - mortality - pathology |
2 |
|
sequence deletion |
2 |
|
sigmoid neoplasms - genetics - mortality - pathology |
2 |
|
survival analysis |
2 |
|
survival rate |
2 |
|
transcriptome-wide association study (twas) |
2 |
|
vesicle-associated membrane protein 8 (vamp8) |
2 |
|
zinc hook domain |
2 |
